This page shows the latest bribery news and features for those working in and with pharma, biotech and healthcare.
$700m as a result of “eye-popping price increase” as well as “monopoly, bribery, racketeering, fraud and other deceptive and unfair practices”.
Cohen, data manipulation involving its gene therapy Zolgensma and bribery and mis-marketing allegations in several countries including the US.
This conduct consists of a complex, multipart scheme involving monopoly, bribery, racketeering, fraud and other deceptive and unfair practices.”. ... Finally, Humana alleges Mallinckrodt maintained the artificially inflated demand “through a
Narasimhan also confirmed that the company was setting aside a sizeable sum of $700m in the hope of settling a bribery lawsuit in the US.
Company faces huge damages pay out
However these and all other gifts have been outlawed, with the aim of eliminating suspicions of bribery or inappropriate influence. ... China's authorities have cracked down on bribery among state employees and healthcare professionals, and fined GSK
More from news
Approximately 15 fully matching, plus 59 partially matching documents found.
One of the most serious concerns is bribery, corruption and fraud, well-known problems in the country in recent times. ... So how does AZ ensure it doesn’t get entangled in bribery or corruption in China?
to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... posing the most significant risks overall”, perhaps due to continued
Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... However, EY’s Global Fraud Survey 2016 shows 11% of company
However, the situation in China was about to change significantly. Christian took up his China Region post in August 2013, when the full ramifications of the bribery scandal at GlaxoSmithKline had
The strengthening of international regulations around anti-bribery – and renewed vigour in their enforcement – has placed pharmaceutical companies under unparalleled scrutiny.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Wanda (pictured) now takes on the role of executive director, anti-bribery and anti-corruption in the Japanese firm's ethics and compliance organisation, reporting to Catherine Wertjec, SVP ethics and
The UK's biggest drugmaker will certainly be hoping this level of experience can be applied by Sir Philip towards rebuilding GSK's reputation in China following the bribery scandal of
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...